MedTech News
.................... by Andrew Celentano
Blood test boosts Alzheimer’s diagnosis accuracy to 94.5%, clinical study shows
A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer’s disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein called p-tau217, affect both the clinical diagnosis of Alzheimer’s and neurologists’ confidence in their diagnosis.
MRI antenna can boost image quality and shorten scan times—without changing existing machines
Magnetic resonance imaging (MRI) is one of medicine’s most powerful diagnostic tools. But certain tissues deep inside the body—including brain regions and delicate structures of the eye and orbit that are of particular relevance for ophthalmology—are difficult to image clearly. The problem is not the scanner itself, but the hardware that sends and receives radio signals.
Scientists develop first-of-its-kind antibody to block Epstein Barr virus
Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions. Using mice with human antibody genes, the research team developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the virus from binding to and entering human immune cells.
Medtronic’s blood pressure device wins coverage nod in Japan
Medtronic is investing in the rollout of the Symplicity Spyral renal denervation procedure, including hiring for new market development roles, CEO Geoff Martha said on an earnings call.
Senseonics launches automated insulin dosing system with 1-year CGM
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
Medtronic renal denervation has a reimbursement win in Japan
Medtronic continues to expand the growth opportunities for its hypertension-treating Symplicity Spyral renal denervation system.
GE HealthCare wins FDA nod for next-gen Signa MRI tech
GE HealthCare (Nasdaq: GEHC)+ announced today that it received FDA clearance for a trio of new MRI offerings.
Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation for OneBreath™ Platform to Aid Pre-Operative Pneumonia Risk Assessment
LOUISVILLE, Ky., Feb. 19, 2026 /PRNewswire/ — Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its OneBreath™ platform.